Holen Sie sich die Stockscreener-App
7.74
0.31%
-0.03
Schlusskurs vom Vortag:
$7.77
Offen:
$7.63
24-Stunden-Volumen:
594.27K
Relative Volume:
0.23
Marktkapitalisierung:
$861.15M
Einnahmen:
$24.30M
Nettoeinkommen (Verlust:
$-145.57M
KGV:
-5.8195
EPS:
-1.33
Netto-Cashflow:
$-149.17M
1W Leistung:
-13.84%
1M Leistung:
-9.19%
6M Leistung:
+419.87%
1J Leistung:
+30.84%
1-Tages-Spanne:
$7.58
$7.89
1-Wochen-Bereich:
$6.69
$9.39
52-Wochen-Spanne:
$1.03
$9.70
Tango Therapeutics Inc Stock (TNGX) Company Profile
Firmenname
Tango Therapeutics Inc
Sektor
Branche
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie TNGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
7.74 | 1.03B | 24.30M | -145.57M | -149.17M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.93 | 107.73B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.49 | 62.04B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
482.61 | 62.73B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
832.77 | 51.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.19 | 34.67B | 398.11M | -1.03B | -868.57M | -5.7032 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-08 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-20 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
Does Tango Therapeutics Inc. fit your quant trading modelBull Run & Risk Managed Trade Strategies - newser.com
Ranking Tango Therapeutics Inc. among high performing stocks via tools2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Tango Therapeutics Inc. stock trend outlook and recovery path2025 Price Action Summary & Free Long-Term Investment Growth Plans - newser.com
Using AI based signals to follow Tango Therapeutics Inc.Market Risk Report & AI Enhanced Execution Alerts - newser.com
How to build a dashboard for Tango Therapeutics Inc. stockWeekly Risk Summary & AI Enhanced Trading Signals - newser.com
Why Tango Therapeutics Inc. stock is trending among retail tradersTrend Reversal & Smart Allocation Stock Tips - newser.com
Tango Therapeutics Advances Innovative Cancer Treatment with S095035 Clinical Trial - TipRanks
Is Tango Therapeutics Inc. stock entering bullish territory2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Revolution Medicines and Tango Therapeutics Advance in Targeted Cancer Therapy Study - TipRanks
Tango Therapeutics’ Promising Update on TNG260 Clinical Study - TipRanks
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors - TipRanks
Tango Therapeutics (TNGX) Upgraded to Buy: Here's Why - Yahoo Finance
Tango Therapeutics stock gains as Cantor Fitzgerald reiterates Overweight rating - Investing.com Nigeria
Multi asset correlation models including Tango Therapeutics Inc.2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Tango Therapeutics Inc. (TNGX) Stock Price | Live Quotes & Charts | NSD - StocksToTrade
Guggenheim Maintains Tango Therapeutics (TNGX) Buy Recommendation - Nasdaq
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.28%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):